Search the Newsreel

AMGEN INC : JEFFERIES RAISES TARGET PRICE TO $385 FROM $346

Jefferies has increased its target price for Amgen Inc. (AMGN) to $385 from $346. This information, provided by Reuters, indicates an analyst's revised valuation for the pharmaceutical company. The article also includes a disclaimer stating that the content reflects only the author's opinion and …

AMGEN INC : OPPENHEIMER RAISES TARGET PRICE TO $450 FROM $400

Oppenheimer has increased its target price for Amgen Inc. to $450 from $400. The article, sourced from Reuters, includes a disclaimer stating that its content reflects only the author's opinion and is not investment advice.

AMGEN INC : TRUIST SECURITIES RAISES TARGET PRICE TO $362 FROM $340

Truist Securities has increased its target price for Amgen Inc. (AMGN) from $340 to $362. This update reflects the analyst firm's revised outlook on the biotechnology company's financial prospects. The information is presented by Reuters.

AMGEN DATA BREACH: Edelson Lechtzin LLP Launches Class

Edelson Lechtzin LLP has launched a class action investigation into a data breach at Amgen Inc. The breach, identified in July 2026, involved unauthorized activity in cloud environments resulting in the exfiltration of patient protected health information and proprietary company data. The law firm …

Amgen raises 2026 EPS, revenue guidance as Q2 beats on both lines (AMGN:NASDAQ)

Amgen (AMGN) has raised its 2026 profit and revenue guidance after reporting strong Q2 financial results that exceeded expectations. The biopharma company now projects full-year non-GAAP EPS between $22.30 and $23.50, and revenue between $38 billion and $39.4 billion, both higher than previous estimates …

IAMGOLD Corp expected to post earnings of 52 cents a share - Earnings Preview

IAMGOLD Corp (TSX:IMG) is projected to report earnings of 52 cents per share, according to a Reuters earnings preview. The full article can be accessed by TradingView subscribers.

Highlights from Amgen's 2026 Second Quarter Earnings Report

Amgen released its 2026 second quarter earnings report, showcasing strong performance driven by key growth drivers that increased 26% year over year and accounted for nearly 70% of product sales. Chairman and CEO Robert A. Bradway expressed confidence in the company's ability to sustain …

Amgen Inc Stock (AMGN) Closed Up by 3.03% on Aug 4: Key Drivers Unveiled

Amgen Inc (AMGN) stock rose by 3.03% due to strong second-quarter earnings that surpassed expectations, positive interim clinical trial data for a metabolic health candidate, and supportive broader market sentiment for defensive healthcare stocks. The company's robust core product portfolio growth, improved operating margins, …

Amgen Lifts Outlook on Strong Drug Sales, to End Early Development of Obesity Treatment

Amgen has raised its full-year revenue outlook to between $38.2 billion and $39.4 billion due to strong drug sales in the second quarter. However, the biotechnology company also announced it would halt the development of AMG 513, an early-stage obesity treatment that was in …

Amgen second-quarter sales rise 9%, profit tops Street view

Amgen reported a 9% rise in second-quarter sales and adjusted earnings that surpassed analyst expectations, driven by strong demand for drugs like Repatha and Evenity. The company also raised its full-year revenue and profit outlook, despite discontinuing an experimental obesity drug candidate (AMG 513). …

What Makes Affiliated Managers Group (AMG) a Strong Momentum Stock: Buy Now?

Affiliated Managers Group (AMG) is identified as a strong momentum stock with a Zacks Rank of #2 (Buy) and a Momentum Style Score of B. The article highlights AMG's impressive short-term and long-term price performance, outperforming its industry and the S&P 500, alongside positive …

Earnings Flash (AMGN) Amgen Inc. Reports Q2 Revenue $10.05B, vs. FactSet Est of $9.43B

Amgen Inc. reported its second-quarter revenue reached $10.05 billion, surpassing FactSet's estimate of $9.43 billion. This earnings flash indicates strong financial performance for the biotechnology group, exceeding analyst expectations for the quarter. The company also announced lifting its outlook on strong Q2 drug sales, …

Affiliated Managers Group, Inc. (AMG) Hits Fresh High: Is There Still Room to Run?

Shares of Affiliated Managers Group (AMG) have been strong performers lately, with the stock up 6.8% over the past month. The stock hit a new 52-week high of $384.11 in the previous session. Affiliated Managers has gained 32.1% since the start of the year …

Amgen Inc. Cloud Data Breach Exposes Patient PHI in 2026 Cybersecurity Incident Analysis

In July 2026, Amgen Inc. disclosed a cybersecurity incident involving unauthorized access to its third-party-hosted cloud storage systems, resulting in the exfiltration of proprietary data and patient PHI. The company promptly initiated its incident response, engaged forensics experts, and notified the SEC. While the …

Hilltop National Bank Has $1.04 Million Position in Amgen Inc. $AMGN

Hilltop National Bank significantly reduced its stake in Amgen Inc. by 58.3% in the second quarter, now holding 2,860 shares valued at approximately $1.04 million. Despite this, institutional investors collectively own 76.5% of Amgen, which recently declared a quarterly dividend of $2.52 per share. …

Amgen Inc. $AMGN Holdings Cut by CX Institutional

CX Institutional significantly reduced its stake in Amgen Inc. by 32% in Q2, selling 12,252 shares and retaining 25,985 shares valued at $9.41 million. Despite a reported data breach posing a near-term risk, analysts maintain a consensus "Hold" rating with a $357 price target, …

Amgen Inc. (NASDAQ:AMGN) Given Average Recommendation of "Hold" by Brokerages

Amgen Inc. (NASDAQ:AMGN) has received a consensus "Hold" recommendation from thirty research firms, with an average 12-month price target of $357.00. While new medicines and potential expansion into type 2 diabetes offer growth opportunities, the company faces a significant near-term risk from a reported …

Amgen (AMGN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Amgen (AMGN) Q2 Earnings and Revenues Surpass Estimates

Amgen (NASDAQ:AMGN) Delivers Strong Q2 CY2026 Numbers, Guides for Strong Full-Year Sales

Affiliated Managers Group, Inc. $AMG Shares Purchased by California State Teachers Retirement System

PRIVACY ALERT: Amgen Under Investigation for Data Breach of Records

Schubert Jonckheer & Kolbe are investigating a data breach at Amgen Inc. that compromised sensitive information, including proprietary data and patient protected health information, from its cloud storage systems in July 2026. Amgen disclosed the "material" breach in an SEC filing but has not …

Amgen Tells SEC Hack Exposed Patient Data, Trade Secrets

Amgen has informed the U.S. Securities and Exchange Commission (SEC) about a June data breach that may have compromised intellectual property, patient information, research and development data, and other confidential business files. The pharmaceutical giant discovered unauthorized activity in July within cloud environments hosted …

Amgen Inc. stock underperforms Monday when compared to competitors

Amgen Inc. (AMGN) stock fell by 1.63% to $378.87 on Monday, underperforming the broader market. This occurred despite a generally favorable trading session where the S&P 500 Index rose 1.48% and the Dow Jones Industrial Average rose 1.32%. This marks the second consecutive day …

Amg stock hits all-time high at 382.86 USD By Investing.com

Affiliated Managers Group Inc (AMG) stock has reached an all-time high of $382.86, trading just 1% below its 52-week high with a market capitalization of $10.11 billion. This surge reflects strong investor confidence and a 78.33% increase over the past year, with the stock …

California drugmaker Amgen reports theft of patient data in cyber incident

Amgen Inc., a California drugmaker, reported a cyber incident involving the theft of patient health information and proprietary data from third-party cloud servers in July. While the company is still assessing the full impact, it currently does not expect the breach to materially affect …

IAMGOLD Corporation (TSX:IMG) Brings Gold Stocks Into Sharp Focus

This article focuses on Canadian gold producers, particularly IAMGOLD Corporation (TSX:IMG), as the reporting season highlights the importance of operational quality, disciplined execution, project delivery, and sustainable cash generation in the mining sector. It mentions that companies like IAMGOLD, Lundin Gold, New Gold, and …

Amgen Reports Data Breach Exposes Protected Health Info

Amgen Inc. disclosed a data breach to the SEC on July 29, 2026, involving unauthorized access and exfiltration of data from third-party cloud environments. The exposed information includes proprietary company data and patient protected health information. Amgen states that there has been no identified …

Amgen contends with data breach, exposing patient information

Amgen has experienced a data breach affecting its third-party cloud-based systems, compromising both company-owned data and private patient health information. The company has initiated its cybersecurity response plan and believes the incident is "not reasonably likely" to materially impact its financial condition or operations. …

Amgen (AMGN) Discloses Material Cybersecurity Incident Involving Data Exfiltration

Amgen (AMGN) has disclosed a material cybersecurity incident involving unauthorized access to data in third-party cloud environments, resulting in the exfiltration of proprietary data, patient protected health information, and other sensitive information. While the investigation is ongoing, Amgen does not currently believe the incident …

Why Affiliated Managers Group (AMG) Could Be a Hidden Winner in Alternatives

Ariel Investments, an investment management company, released its "Ariel Focus Fund" Q2 2026 investor letter. A copy of the letter can be downloaded here. The Fund returned 2.14% in the second quarter of 2026, underperforming the Russell 1000 Value and S&P 500, which gained …

AmGen Announces Cyberattack and Data Breach Involving Patient Data

Amgen Inc. has disclosed a cybersecurity incident where unauthorized actors accessed third-party cloud storage systems, exfiltrating proprietary data and patients’ protected health information. The biopharmaceutical company reported the material incident to the SEC, initiated an investigation with digital forensics experts, and is currently assessing …

Kaléo Announces License Agreement with Amgen for Auto-Injector Technology

Kaléo announced a confidential license agreement with Amgen Inc., granting Amgen access to Kaléo's patented auto-injector technology. This agreement highlights Kaléo's leadership in drug-device technologies and patient-centric auto-injector solutions, though the financial terms were not disclosed. Kaléo specializes in drug-delivery device technology and auto-injector …

3,522 Shares in Amgen Inc. $AMGN Bought by VectorGlobal IAG Inc.

VectorGlobal IAG Inc. recently acquired 3,522 shares of Amgen Inc. (NASDAQ:AMGN) worth approximately $1.24 million, making it a new stakeholder in the biotechnology company. Institutional investors collectively own 76.5% of Amgen's stock, which has seen positive news like an expanded European recommendation for Repatha …

Segall Bryant & Hamill LLC Buys Shares of 23,026 Amgen Inc. $AMGN

Segall Bryant & Hamill LLC has acquired 23,026 shares of Amgen Inc., valued at approximately $8.7 million, marking a new position for the institutional investor. Amgen exceeded its Q1 earnings expectations, reporting $5.15 EPS against an $8.62 billion revenue, and declared a quarterly dividend …

Amgen (AMGN) To Report Earnings Tomorrow: Here Is What To Expect

Amgen (AMGN) is scheduled to report its earnings tomorrow. Analysts expect revenue growth of 2.4% year-on-year, a slowdown from the previous year. The company has a history of meeting or beating Wall Street's revenue estimates, and peer companies like Biogen and Moderna have recently …